Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial.

Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, Thorpe K, Champagne J, Talajic M, Coutu B, Gronefeld GC, Hohnloser SH; Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Investigators..

JAMA. 2006 Jan 11;295(2):165-71.

PMID:
16403928
2.

Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.

Bollmann A, Husser D, Cannom DS.

Am J Cardiovasc Drugs. 2005;5(6):371-8. Review.

PMID:
16259525
3.

Sotalol: An important new antiarrhythmic.

Anderson JL, Prystowsky EN.

Am Heart J. 1999 Mar;137(3):388-409. Review.

PMID:
10047618
4.

Adjunctive antiarrhythmic drug therapy in patients with implantable cardioverter defibrillators: a systematic review.

Ferreira-González I, Dos-Subirá L, Guyatt GH.

Eur Heart J. 2007 Feb;28(4):469-77. Review.

PMID:
17227788
5.

Role of antiarrhythmic drugs: frequent implantable cardioverter-defibrillator shocks, risk of proarrhythmia, and new drug therapy.

Droogan C, Patel C, Yan GX, Kowey PR.

Heart Fail Clin. 2011 Apr;7(2):195-205, viii. doi: 10.1016/j.hfc.2010.12.003. Review.

PMID:
21439498
6.

Adjuvant antiarrhythmic therapy in patients with implantable cardioverter defibrillators.

Bunch TJ, Anderson JL.

Am J Cardiovasc Drugs. 2014 Apr;14(2):89-100. doi: 10.1007/s40256-013-0056-x. Review.

PMID:
24288157
7.
8.

Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia.

Van Herendael H, Dorian P.

Vasc Health Risk Manag. 2010 Aug 9;6:465-72. Review.

9.

Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock.

Mishkin JD, Saxonhouse SJ, Woo GW, Burkart TA, Miles WM, Conti JB, Schofield RS, Sears SF, Aranda JM Jr.

J Am Coll Cardiol. 2009 Nov 24;54(22):1993-2000. doi: 10.1016/j.jacc.2009.07.039. Review.

10.

Drugs versus devices in controlling ventricular tachycardia, ventricular fibrillation, and recurrent cardiac arrest.

Haverkamp W, Eckardt L, Borggrefe M, Breithardt G.

Am J Cardiol. 1997 Oct 23;80(8A):67G-73G. Review.

PMID:
9354413
11.

[Antiarrhythmic therapy in patients with heart failure].

Faber TS, Zehender M.

Ther Umsch. 2000 May;57(5):324-32. Review. German.

PMID:
10859993
12.

Implanted cardioverter-defibrillators are preferable to drugs as primary therapy in sustained ventricular tachyarrhythmias.

Saksena S, Madan N, Lewis C.

Prog Cardiovasc Dis. 1996 May-Jun;38(6):445-54. Review.

PMID:
8638025
13.

Is primary antiarrhythmic drug therapy for ventricular arrhythmias obsolete?

Cooley R, Akhtar M, Sra J.

Curr Cardiol Rep. 1999 Nov;1(4):268-73. Review.

PMID:
10980853
14.

New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.

Klein H, Auricchio A, Reek S, Geller C.

Am J Cardiol. 1999 Mar 11;83(5B):91D-97D. Review.

PMID:
10089848
15.

The role of EP-guided therapy in ventricular arrhythmias: beta-blockers, sotalol, and ICD's.

Capucci A, Aschieri D, Villani GQ.

J Interv Card Electrophysiol. 2000 Jan;4 Suppl 1:57-63. Review.

PMID:
10590490
16.
17.

Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.

Arsenault KA, Yusuf AM, Crystal E, Healey JS, Morillo CA, Nair GM, Whitlock RP.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD003611. doi: 10.1002/14651858.CD003611.pub3. Review.

PMID:
23440790
18.

Implantable cardioverter-defibrillator shocks: epidemiology, outcomes, and therapeutic approaches.

Borne RT, Varosy PD, Masoudi FA.

JAMA Intern Med. 2013 May 27;173(10):859-65. doi: 10.1001/jamainternmed.2013.428. Review.

PMID:
23546173
19.

Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based review.

Hilleman DE, Bauman AL.

Pharmacotherapy. 2001 May;21(5):556-75. Review.

PMID:
11349745
20.

[Current role of amiodarone in antiarrhythmic therapy].

Sohns C, Zabel M.

Herzschrittmacherther Elektrophysiol. 2010 Dec;21(4):239-43. doi: 10.1007/s00399-010-0091-0. Review. German.

PMID:
21104260

Supplemental Content

Support Center